1887

Abstract

The relationship between hepatitis B virus (HBV) infection and lipid accumulation remains largely unknown. In this study, we investigated the effect of HBV propagation on lipid droplet growth in HBV-infected cells and HBV-producing cell lines, HepG2.2.15 and HBV-inducible Hep38.7-Tet. The amount of intracellular triglycerides was significantly reduced in HBV-infected and HBV-producing cells compared with HBV-lacking control cells. Electron and immunofluorescent microscopic analyses showed that the average size of a single lipid droplet (LD) was significantly less in the HBV-infected and HBV-producing cells than in the HBV-lacking control cells. Cell death-inducing DFF45-like effectors (CIDEs) B and C (CIDEB and CIDEC), which are involved in LD expansion for the improvement of lipid storage, were expressed at a significantly lower level in HBV-infected or HBV-producing cells than in HBV-lacking control cells, while CIDEA was not detected in those cells regardless of HBV production. The activity of the CIDEB and CIDEC gene promoters was impaired in HBV-infected or HBV-producing cells compared to HBV-lacking control cells, while CIDEs potentiated HBV core promoter activity. The amount of HNF4α, that can promote the transcription of CIDEB was significantly lower in HBV-producing cells than in HBV-lacking control cells. Knockout of CIDEB or CIDEC significantly reduced the amount of supernatant HBV DNA, intracellular viral RNA and nucleocapsid-associated viral DNA, while the expression of CIDEB or CIDEC recovered HBV production in CIDEB- or CIDEC-knockout cells. These results suggest that HBV regulates its own viral replication via CIDEB and CIDEC.

Keyword(s): CIDEB , CIDEC , HBV and hepatitis B
Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.000813
2017-07-24
2019-09-21
Loading full text...

Full text loading...

/deliver/fulltext/jgv/98/7/1762.html?itemId=/content/journal/jgv/10.1099/jgv.0.000813&mimeType=html&fmt=ahah

References

  1. Kwon H, Lok AS. Hepatitis B therapy. Nat Rev Gastro Hepat 2011;8:275–284
    [Google Scholar]
  2. Lok AS. Chronic hepatitis B. N Engl J Med 2002;346:1682–1683 [CrossRef][PubMed]
    [Google Scholar]
  3. Lai CL, Ratziu V, Yuen MF, Poynard T. Viral hepatitis B. Lancet 2003;362:2089–2094 [CrossRef][PubMed]
    [Google Scholar]
  4. Kim KH, Shin HJ, Kim K, Choi HM, Rhee SH et al. Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARγ. Gastroenterology 2007;132:1955–1967 [CrossRef][PubMed]
    [Google Scholar]
  5. Wu YL, Peng XE, Zhu YB, Yan XL, Chen WN et al. Hepatitis B virus X protein induces hepatic steatosis by enhancing the expression of liver fatty acid binding protein. J Virol 2015;90:1729–1740 [CrossRef][PubMed]
    [Google Scholar]
  6. Cui M, Xiao Z, Sun B, Wang Y, Zheng M et al. Involvement of cholesterol in hepatitis B virus X protein-induced abnormal lipid metabolism of hepatoma cells via up-regulating miR-205-targeted ACSL4. Biochem Biophys Res Commun 2014;445:651–655 [CrossRef][PubMed]
    [Google Scholar]
  7. Cho HK, Kim SY, Yoo SK, Choi YH, Cheong J. Fatty acids increase hepatitis B virus X protein stabilization and HBx-induced inflammatory gene expression. FEBS J 2014;281:2228–2239 [CrossRef][PubMed]
    [Google Scholar]
  8. Teng CF, Wu HC, Hsieh WC, Tsai HW, Su IJ. Activation of ATP citrate lyase by mTOR signal induces disturbed lipid metabolism in hepatitis B virus pre-S2 mutant tumorigenesis. J Virol 2015;89:605–614 [CrossRef][PubMed]
    [Google Scholar]
  9. Wong VW, Wong GL, Chu WC, Chim AM, Ong A et al. Hepatitis B virus infection and fatty liver in the general population. J Hepatol 2012;56:533–540 [CrossRef][PubMed]
    [Google Scholar]
  10. Machado MV, Oliveira AG, Cortez-Pinto H. Hepatic steatosis in hepatitis B virus infected patients: meta-analysis of risk factors and comparison with hepatitis C infected patients. J Gastroenterol Hepatol 2011;26:1361–1367 [CrossRef][PubMed]
    [Google Scholar]
  11. Cheng YL, Wang YJ, Kao WY, Chen PH, Huo TI et al. Inverse association between hepatitis B virus infection and fatty liver disease: a large-scale study in populations seeking for check-up. PLoS One 2013;8:e72049 [CrossRef][PubMed]
    [Google Scholar]
  12. Joo EJ, Chang Y, Yeom JS, Ryu S. Hepatitis B virus infection and decreased risk of nonalcoholic fatty liver disease: a cohort study. Hepatology 2017;65:828–835 [CrossRef][PubMed]
    [Google Scholar]
  13. Gong J, Sun Z, Li P. CIDE proteins and metabolic disorders. Curr Opin Lipidol 2009;20:121–126 [CrossRef][PubMed]
    [Google Scholar]
  14. Li JZ, Ye J, Xue B, Qi J, Zhang J et al. Cideb regulates diet-induced obesity, liver steatosis, and insulin sensitivity by controlling lipogenesis and fatty acid oxidation. Diabetes 2007;56:2523–2532 [CrossRef][PubMed]
    [Google Scholar]
  15. Nishino N, Tamori Y, Tateya S, Kawaguchi T, Shibakusa T et al. FSP27 contributes to efficient energy storage in murine white adipocytes by promoting the formation of unilocular lipid droplets. J Clin Invest 2008;118:2808–2821 [CrossRef][PubMed]
    [Google Scholar]
  16. Rubio-Cabezas O, Puri V, Murano I, Saudek V, Semple RK et al. Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC. EMBO Mol Med 2009;1:280–287 [CrossRef][PubMed]
    [Google Scholar]
  17. Zhou Z, Yon Toh S, Chen Z, Guo K, Ng CP et al. Cidea-deficient mice have lean phenotype and are resistant to obesity. Nat Genet 2003;35:49–56 [CrossRef][PubMed]
    [Google Scholar]
  18. Lin SC, Li P. CIDE-A, a novel link between brown adipose tissue and obesity. Trends Mol Med 2004;10:434–439 [CrossRef][PubMed]
    [Google Scholar]
  19. Inohara N, Koseki T, Chen S, Wu X, Núñez G. CIDE, a novel family of cell death activators with homology to the 45 kDa subunit of the DNA fragmentation factor. EMBO J 1998;17:2526–2533 [CrossRef][PubMed]
    [Google Scholar]
  20. Langhi C, Baldán Á. CIDEC/FSP27 is regulated by peroxisome proliferator-activated receptor α and plays a critical role in fasting- and diet-induced hepatosteatosis. Hepatology 2015;61:1227–1238 [CrossRef][PubMed]
    [Google Scholar]
  21. Puri V, Ranjit S, Konda S, Nicoloro SM, Straubhaar J et al. Cidea is associated with lipid droplets and insulin sensitivity in humans. Proc Natl Acad Sci USA 2008;105:7833–7838 [CrossRef][PubMed]
    [Google Scholar]
  22. Nordström EA, Rydén M, Backlund EC, Dahlman I, Kaaman M et al. A human-specific role of cell death-inducing DFFA (DNA fragmentation factor-α)-like effector A (CIDEA) in adipocyte lipolysis and obesity. Diabetes 2005;54:1726–1734 [CrossRef][PubMed]
    [Google Scholar]
  23. Ye J, Li JZ, Liu Y, Li X, Yang T et al. Cideb, an ER- and lipid droplet-associated protein, mediates VLDL lipidation and maturation by interacting with apolipoprotein B. Cell Metab 2009;9:177–190 [CrossRef][PubMed]
    [Google Scholar]
  24. Cai H, Yao W, Li L, Li X, Hu L et al. Cell-death-inducing DFFA-like effector B contributes to the assembly of Hepatitis C virus (HCV) Particles and Interacts with HCV NS5A. Sci Rep 2016;6:27778 [CrossRef][PubMed]
    [Google Scholar]
  25. Wu X, Lee EM, Hammack C, Robotham JM, Basu M et al. Cell death-inducing DFFA-like effector b is required for hepatitis C virus entry into hepatocytes. J Virol 2014;88:8433–8444 [CrossRef][PubMed]
    [Google Scholar]
  26. Singaravelu R, Delcorde J, Lyn RK, Steenbergen RH, Jones DM et al. Investigating the antiviral role of cell death-inducing DFF45-like effector B in HCV replication. FEBS J 2014;281:3751–3765 [CrossRef][PubMed]
    [Google Scholar]
  27. Sells MA, Chen ML, Acs G. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci USA 1987;84:1005–1009 [CrossRef][PubMed]
    [Google Scholar]
  28. Ogura N, Watashi K, Noguchi T, Wakita T. Formation of covalently closed circular DNA in Hep38.7-Tet cells, a tetracycline inducible hepatitis B virus expression cell line. Biochem Biophys Res Commun 2014;452:315–321 [CrossRef][PubMed]
    [Google Scholar]
  29. Okuyama-Dobashi K, Kasai H, Tanaka T, Yamashita A, Yasumoto J et al. Hepatitis B virus efficiently infects non-adherent hepatoma cells via human sodium taurocholate cotransporting polypeptide. Sci Rep 2015;5:17047 [CrossRef][PubMed]
    [Google Scholar]
  30. Yamashita A, Fujimoto Y, Tamaki M, Setiawan A, Tanaka T et al. Identification of antiviral agents targeting Hepatitis B virus promoter from extracts of indonesian Marine organisms by a novel Cell-Based Screening assay. Mar Drugs 2015;13:6759–6773 [CrossRef][PubMed]
    [Google Scholar]
  31. Wang W, Lv N, Zhang S, Shui G, Qian H et al. Cidea is an essential transcriptional coactivator regulating mammary gland secretion of milk lipids. Nat Med 2012;18:235–243 [CrossRef][PubMed]
    [Google Scholar]
  32. Da L, Li D, Yokoyama KK, Li T, Zhao M. Dual promoters control the cell-specific expression of the human cell death-inducing DFF45-like effector B gene. Biochem J 2006;393:779–788 [CrossRef][PubMed]
    [Google Scholar]
  33. Daigo K, Kawamura T, Ohta Y, Ohashi R, Katayose S et al. Proteomic analysis of native hepatocyte nuclear factor-4α (HNF4α) isoforms, phosphorylation status, and interactive cofactors. J Biol Chem 2011;286:674–686 [CrossRef][PubMed]
    [Google Scholar]
  34. Matsusue K, Kusakabe T, Noguchi T, Takiguchi S, Suzuki T et al. Hepatic steatosis in leptin-deficient mice is promoted by the PPARγ target gene Fsp27. Cell Metab 2008;7:302–311 [CrossRef][PubMed]
    [Google Scholar]
  35. Yu S, Matsusue K, Kashireddy P, Cao WQ, Yeldandi V et al. Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor γ1 (PPARγ1) overexpression. J Biol Chem 2003;278:498–505 [CrossRef][PubMed]
    [Google Scholar]
  36. Wu Q, Liu HO, Liu YD, Liu WS, Pan D et al. Decreased expression of hepatocyte nuclear factor 4α (Hnf4α)/microRNA-122 (miR-122) axis in hepatitis B virus-associated hepatocellular carcinoma enhances potential oncogenic GALNT10 protein activity. J Biol Chem 2015;290:1170–1185 [CrossRef][PubMed]
    [Google Scholar]
  37. Zhao Q, Fan YC, Zhao J, Gao S, Zhao ZH et al. DNA methylation patterns of peroxisome proliferator-activated receptor γ gene associated with liver fibrosis and inflammation in chronic hepatitis B. J Viral Hepat 2013;20:430–437 [CrossRef][PubMed]
    [Google Scholar]
  38. Chung TH, Kim MC, Kim CS. Association between Hepatitis B surface antigen seropositivity and metabolic syndrome. Korean J Fam Med 2014;35:81–89 [CrossRef][PubMed]
    [Google Scholar]
  39. Jinjuvadia R, Liangpunsakul S. Association between metabolic syndrome and its individual components with viral hepatitis B. Am J Med Sci 2014;347:23–27 [CrossRef][PubMed]
    [Google Scholar]
  40. Nissim O, Melis M, Diaz G, Kleiner DE, Tice A et al. Liver regeneration signature in hepatitis B virus (HBV)-associated acute liver failure identified by gene expression profiling. PLoS One 2012;7:e49611 [CrossRef][PubMed]
    [Google Scholar]
  41. Ladner SK, Otto MJ, Barker CS, Zaifert K, Wang GH et al. Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication. Antimicrob Agents Chemother 1997;41:1715–1720[PubMed]
    [Google Scholar]
  42. Shibata M, Yoshimura K, Furuya N, Koike M, Ueno T et al. The MAP1-LC3 conjugation system is involved in lipid droplet formation. Biochem Biophys Res Commun 2009;382:419–423 [CrossRef][PubMed]
    [Google Scholar]
  43. Huang DC, Cory S, Strasser A. Bcl-2, Bcl-XL and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death. Oncogene 1997;14:405–414 [CrossRef][PubMed]
    [Google Scholar]
  44. Sugiyama M, Tanaka Y, Kato T, Orito E, Ito K et al. Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigens. Hepatology 2006;44:915–924 [CrossRef][PubMed]
    [Google Scholar]
  45. Kasai H, Kawakami K, Yokoe H, Yoshimura K, Matsuda M et al. Involvement of FKBP6 in hepatitis C virus replication. Sci Rep 2015;5:16699 [CrossRef][PubMed]
    [Google Scholar]
  46. Zhang YL, Cheng T, Cai YJ, Yuan Q, Liu C et al. RNA interference inhibits hepatitis B virus of different genotypes in vitro and in vivo. BMC Microbiol 2010;10:214 [CrossRef][PubMed]
    [Google Scholar]
  47. Kim YJ, Cho SY, Yun CH, Moon YS, Lee TR et al. Transcriptional activation of cidec by PPARγ2 in adipocyte. Biochem Biophys Res Commun 2008;377:297–302 [CrossRef][PubMed]
    [Google Scholar]
  48. Fujihara Y, Ikawa M. CRISPR/Cas9-based genome editing in mice by single plasmid injection. Methods Enzymol 2014;546:319–336 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.000813
Loading
/content/journal/jgv/10.1099/jgv.0.000813
Loading

Data & Media loading...

Supplementary File 1

PDF

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error